Skip to main content
Clinical Trials/NL-OMON21687
NL-OMON21687
Recruiting
Not Applicable

Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?

Erasmus MC0 sites122 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Antipsychotics, intellectual disabilitiesAntipsychotica, verstandelijke beperking
Sponsor
Erasmus MC
Enrollment
122
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

  1. Beumer S, Festen, D. Reduction or discontinuation of antipsychotics for challenging behavior in adults with intellectual disability: why does it fail?” Lancet Psychiatry. Vol 4, No3 e2,March 2017
Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Adults with ID (IQ \< 70\), using off\-label antipsychotics (pipamperone or risperidone) since \> 1 year for behavioral problems.
  • Participants are living (\=\>ZZP4\) in three participating ID care organizations of the HA\-ID consort.

Exclusion Criteria

  • Diagnosis of psychosis, dementia, schizophrenia, psychotic disorder NOS, delirium, failed attempt to withdraw AP \< 6 months ago, usage of \>1 AP drug

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?
NL-OMON55806Erasmus MC, Universitair Medisch Centrum Rotterdam122
Active, not recruiting
Phase 1
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?People with challenging behavior and off-label antipsychotic useTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2016-002859-19-NLErasmus MC
Active, not recruiting
Phase 1
RADAR TrialSchizophrenia, delusional disorders, schizoaffective disorder, psychosisMedDRA version: 20.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: HLTClassification code 10012256Term: Delusional disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10039621Term: Schizoaffective disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: LLTClassification code 10037234Term: PsychosisSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2016-000709-36-GBC402
Recruiting
Phase 4
discontinuation of combination antipsychotics to monotherapy: risk or added value?psychosisschizophrenia10039628
NL-OMON32961Symforagroep (Amersfoort)160
Active, not recruiting
Not Applicable
Deprescribing of antipsychotics of patients with dementia in long term care - an intervention studyF03Unspecified dementia
DRKS00017831Medizinische Fakultät der TU München, Klinik und Poliklinik für Psychiatrie und Psychotherapie32